• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

醛固酮抵抗:结构和功能的考虑因素及新视角。

Aldosterone resistance: structural and functional considerations and new perspectives.

机构信息

INSERM U970, Paris Cardiovascular Research Center, Paris, France.

出版信息

Mol Cell Endocrinol. 2012 Mar 24;350(2):206-15. doi: 10.1016/j.mce.2011.04.023. Epub 2011 Jun 1.

DOI:10.1016/j.mce.2011.04.023
PMID:21664233
Abstract

Aldosterone plays an essential role in the maintenance of fluid and electrolyte homeostasis in the distal nephron. Loss-of-function mutations in two key components of the aldosterone response, the mineralocorticoid receptor and the epithelial sodium channel ENaC, lead to type 1 pseudohypoaldosteronism (PHA1), a rare genetic disease of aldosterone resistance characterized by salt wasting, dehydration, failure to thrive, hyperkalemia and metabolic acidosis. This review describes the clinical, biological and genetic characteristics of the different forms of PHA1 and highlights recent advances in the understanding of the pathogenesis of the disease. We will also discuss genotype-phenotype correlations and new clinical and genetic entities that may prove relevant for patient's care in neonates with renal salt losing syndromes and/or failure to thrive.

摘要

醛固酮在维持远端肾单位的液体和电解质稳态中起着至关重要的作用。醛固酮反应的两个关键组成部分,即盐皮质激素受体和上皮钠通道 ENaC 的失功能突变,导致 1 型假性醛固酮减少症(PHA1),这是一种罕见的醛固酮抵抗性遗传疾病,其特征为盐耗竭、脱水、生长不良、高钾血症和代谢性酸中毒。本综述描述了不同形式的 PHA1 的临床、生物学和遗传学特征,并强调了对疾病发病机制的理解的最新进展。我们还将讨论基因型-表型相关性以及新的临床和遗传实体,这些实体可能与新生儿肾性盐丢失综合征和/或生长不良患者的治疗相关。

相似文献

1
Aldosterone resistance: structural and functional considerations and new perspectives.醛固酮抵抗:结构和功能的考虑因素及新视角。
Mol Cell Endocrinol. 2012 Mar 24;350(2):206-15. doi: 10.1016/j.mce.2011.04.023. Epub 2011 Jun 1.
2
Mineralocorticoid resistance.盐皮质激素抵抗
Trends Endocrinol Metab. 2004 Aug;15(6):264-70. doi: 10.1016/j.tem.2004.06.003.
3
Clinical and molecular features of type 1 pseudohypoaldosteronism.1型假性醛固酮减少症的临床和分子特征
Horm Res. 2009;72(1):1-9. doi: 10.1159/000224334. Epub 2009 Jun 30.
4
Pseudohypoaldosteronism.假性醛固酮减少症
Endocr Dev. 2013;24:86-95. doi: 10.1159/000342508. Epub 2013 Feb 1.
5
Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism.盐皮质激素受体突变是肾性1型假性醛固酮增多症的主要病因。
Hum Mutat. 2007 Jan;28(1):33-40. doi: 10.1002/humu.20371.
6
Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism.I型假性醛固酮增多症中盐皮质激素受体的失活突变。
Mol Cell Endocrinol. 2004 Mar 31;217(1-2):119-25. doi: 10.1016/j.mce.2003.10.017.
7
[Mineralocorticoid resistance: pseudohypoaldosteronism type 1].[盐皮质激素抵抗:1型假性醛固酮增多症]
Arq Bras Endocrinol Metabol. 2007 Apr;51(3):373-81. doi: 10.1590/s0004-27302007000300004.
8
Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I.盐皮质激素受体基因突变导致常染色体显性遗传I型假性醛固酮减少症。
Nat Genet. 1998 Jul;19(3):279-81. doi: 10.1038/966.
9
30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor mutations.盐皮质激素受体的30年:盐皮质激素受体突变
J Endocrinol. 2017 Jul;234(1):T93-T106. doi: 10.1530/JOE-17-0089. Epub 2017 Mar 27.
10
Functional polymorphisms in the mineralocorticoid receptor and amirolide-sensitive sodium channel genes in a patient with sporadic pseudohypoaldosteronism.一名散发性假性醛固酮减少症患者盐皮质激素受体和氨氯地平敏感钠通道基因的功能多态性
Hum Genet. 2003 Jan;112(1):91-7. doi: 10.1007/s00439-002-0855-7. Epub 2002 Oct 25.

引用本文的文献

1
Clinical and Biochemical Characteristics of Pseudohypoaldosteronism Type 1 with and Without Genetic Mutations: A Literature Review.伴有和不伴有基因突变的1型假性醛固酮减少症的临床和生化特征:文献综述
J Clin Med. 2025 Jun 20;14(13):4408. doi: 10.3390/jcm14134408.
2
Renal calcification in children with renal tubular acidosis: What a paediatrician ‎should ‎know‎.肾小管酸中毒患儿的肾钙化:儿科医生应了解的知识
World J Clin Pediatr. 2023 Dec 9;12(5):295-309. doi: 10.5409/wjcp.v12.i5.295.
3
Acid-Base Imbalance in Pseudohypoaldosteronism Type 1 in Comparison With Type IV Renal Tubular Acidosis.
1型假性醛固酮减少症与IV型肾小管酸中毒的酸碱失衡比较
J Endocr Soc. 2022 Sep 27;6(12):bvac147. doi: 10.1210/jendso/bvac147. eCollection 2022 Oct 26.
4
Mechanistic insights into the primary and secondary alterations of renal ion and water transport in the distal nephron.深入了解远曲小管中肾脏离子和水转运的原发性和继发性改变的机制。
J Intern Med. 2023 Jan;293(1):4-22. doi: 10.1111/joim.13552. Epub 2022 Aug 21.
5
Case Report: A Novel Compound Heterozygote Mutation of the Gene Identified in a Chinese Familial Pseudohypoaldosteronism Disease Type I With Persistent Hyperkalemia.病例报告:在中国一例伴有持续性高钾血症的I型家族性假性醛固酮增多症疾病中鉴定出该基因的一种新型复合杂合子突变。
Front Pediatr. 2022 Mar 10;10:831284. doi: 10.3389/fped.2022.831284. eCollection 2022.
6
A Novel Variation in a Patient with Autosomal-recessive Pseudohypoaldosteronism Type 1.一例常染色体隐性遗传假性醛固酮减少症 1 型患者的新变异。
J Clin Res Pediatr Endocrinol. 2022 Jun 7;14(2):244-250. doi: 10.4274/jcrpe.galenos.2021.2020.0175. Epub 2021 Apr 8.
7
Dietary potassium restriction attenuates urinary sodium wasting in the generalized form of pseudohypoaldosteronism type 1.饮食钾限制减轻 1 型假性醛固酮增多症广义型的尿钠浪费。
CEN Case Rep. 2020 May;9(2):133-137. doi: 10.1007/s13730-019-00441-0. Epub 2020 Jan 3.
8
One-month-old girl presenting with pseudohypoaldosteronism leading to the diagnosis of CDK13-related disorder: a case report and review of the literature.一名1个月大女童因假性醛固酮减少症就诊,最终诊断为与CDK13相关的疾病:病例报告及文献复习
J Med Case Rep. 2019 Dec 29;13(1):386. doi: 10.1186/s13256-019-2319-x.
9
An infant with hyponatremia, hyperkalemia, and metabolic acidosis associated with urinary tract infection: Answers.一名患有低钠血症、高钾血症和代谢性酸中毒且与尿路感染相关的婴儿:答案。
Pediatr Nephrol. 2019 Oct;34(10):1739-1741. doi: 10.1007/s00467-019-04254-2. Epub 2019 May 3.
10
Rare Cause of Hyperkalemia in the Newborn Period: Report of Two Cases of Pseudohypoaldosteronism Type 1.新生儿期高钾血症的罕见病因:两例1型假性醛固酮减少症病例报告
Indian J Nephrol. 2018 Jan-Feb;28(1):69-72. doi: 10.4103/ijn.IJN_258_14.